Board of Directors

Eric Reiman, M.D.

Chair

Dr. Eric Reiman joined the Flinn Foundation Board of Directors in 1999 and was elected chair in 2023. He previously had served as secretary since 2008. He is executive director of Banner Alzheimer’s Institute, chief executive officer of Banner Research, professor of psychiatry at the University of Arizona, University Professor of neuroscience at Arizona State University, senior scientist at the Translational Genomics Research Institute, director of the Arizona Alzheimer’s Consortium and NIH-sponsored Arizona Alzheimer’s Disease Research Center, and a leader of the Alzheimer’s Prevention Initiative. He is also a co-founder and advisor to ALZPath, a start-up company that aims to advance the role of blood tests in Alzheimer’s disease research, clinical trials, and clinical care.

A psychiatrist and brain-imaging researcher by background, Dr. Reiman’s interests include brain imaging, blood-based biomarkers, APOE and genomics research, the unusually early detection, tracking, and study of Alzheimer’s disease, the accelerated evaluation of Alzheimer’s prevention therapies, and new models of research collaboration and clinical care. He is an author of more than 650 publications, a principal investigator of several large research NIH grants and other state and foundation grants and contracts, a former member of the National Advisory Council on Aging, and a recipient of the Potamkin Prize for his pioneering contributions to the early detection, prevention, and study of Alzheimer’s disease. His overarching goal is to find and support the approval, affordability, and widespread availability of effective Alzheimer’s prevention therapies within the next few years.

Dr. Reiman graduated from Duke University, studied at Oxford University, and returned to Duke for his medical degree and the first three years of his psychiatry residency. Before moving to Arizona, he completed his psychiatry residency and research fellowship at the Washington University School of Medicine in St. Louis, where he was a faculty member and embarked on a research career in the lab that invented positron emission tomography (PET).